Associate Professor Katherine Samaras Related News
Weight loss reduces artery stiffness in Type 2 diabetes
MEDIA RELEASE:
02 May 2012
A Garvan study shows that losing 6 kg reduces artery stiffness by 20% in obese people with Type 2 diabetes. Diabetes carries a six-fold greater risk of heart disease due to atherosclerosis, or hardening of the arteries. Cardiovascular disease is the commonest cause of death in people with diabetes – accounting for 68% of all deaths.
Fighting illnesses that accompany the latest anti-psychotic drugs
MEDIA RELEASE:
11 Jan 2012
Anti-psychotic drugs for treating serious mental illnesses, such as bipolar disorder or schizophrenia, are effective and often life-saving but come with unwelcome side effects. They dramatically increase weight as well as the incidence of metabolic disorders such as raised blood fats and Type 2 diabetes, say Sydney-based specialists. The rapid decline in physical health is so clinically significant, and of such concern, that the specialists put together a physical health protection algorithm last year.
Why a common HIV drug increases risk of heart attack
MEDIA RELEASE:
28 Jul 2010
Clinical researchers at Garvan and St. Vincent's Hospital have for the first time shown why a commonly used type of HIV drug is associated with a higher risk of heart attack.
The remarkable effects of fat loss on the immune system
MEDIA RELEASE:
20 Apr 2010
Garvan scientists have shown for the first time that even modest weight loss reverses many of the damaging changes often seen in the immune cells of obese people, particularly those with Type 2 diabetes.
Research Fellowship announcement to support link between weight loss and the reversal of Type 2 diabetes
MEDIA RELEASE:
27 Oct 2009
Associate Professor Katherine Samaras is the new recipient of the GlaxoSmithKline (GSK) Don Chisholm Diabetes Research Fellowship. The Fellowship is dedicated to funding vital research into the causes, processes and treatments for Type 2 diabetes, one of Australia’s most common and serious diseases – and is named in honour of Professor Don Chisholm, who is recognised as a leader in clinical diabetes research.
Why HIV treatment makes people so susceptible to heart disease and diabetes
MEDIA RELEASE:
17 Nov 2008
Clinicians have known for some time that people treated for HIV also become much more susceptible to diabetes and heart disease. A study by scientists at Sydney’s Garvan Institute of Medical Research has now shown some of the reasons why – enabling better patient management and monitoring.
